Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 3 | 8 | 3 | 3 | 3 |
| Gross Profit | 3 | 8 | 3 | 3 | 3 |
| Operating Expenses | 2,127 | 1,926 | 2,459 | 1,807 | 2,085 |
| Operating Income | -2,124 | -1,918 | -2,457 | -1,805 | -2,083 |
| Interest Expense | 2 | 1 | 2 | 4 | 2 |
| Other Income | 363 | 482 | -655 | 1,488 | 254 |
| Pre-tax Income | -1,763 | -1,437 | -3,114 | -320 | -1,830 |
| Net Income Continuous | -1,763 | -1,437 | -3,114 | -320 | -1,830 |
| Net Income | $-1,763 | $-1,437 | $-3,114 | $-320 | $-1,830 |
| EPS Basic Total Ops | -2,653.14 | -6,520.44 | -15,379.23 | -6,745.28 | -10,837.41 |
| EPS Basic Continuous Ops | -2,664.16 | -6,501.58 | -15,371.20 | -6,571.19 | -10,843.89 |
| EPS Diluted Total Ops | -2,653.14 | -6,520.44 | -15,379.23 | -6,745.28 | -10,837.41 |
| EPS Diluted Continuous Ops | -2,664.16 | -6,501.58 | -15,371.20 | -6,571.19 | -10,843.89 |
| EBITDA(a) | $-2,088 | $-1,881 | $-2,417 | $-1,780 | $-2,037 |